ConductScience.org, home

Paper23698643

Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.

Scott SA and 10 others. Clin Pharmacol Ther, 2013. Cited by 722 papers, by iCite.

Cite this record

ConductScience Library. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Papers, record 23698643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23698643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
2013
PubMed
Publication types
Journal Article, Practice Guideline, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
722
iCite
Relative citation ratio, by iCite
23.6
iCite
Revised in PubMed
2024-08-29
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Scott SAS A
2Sangkuhl KK
3Stein CMC M
4Hulot JSJ-S
5Mega JLJ L
6Roden DMD M
7Klein TET E
8Sabatine MSM S
9Johnson JAJ A
10Shuldiner ARA R
11Clinical Pharmacogenetics Implementation ConsortiumGroup

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aryl Hydrocarbon HydroxylasesMajor topic
Platelet Aggregation InhibitorsMajor topic
TiclopidineMajor topic
Clopidogrel
Cytochrome P-450 CYP2C19
Genetic Testing
Genetic Variation
Genotype
Humans
Risk Assessment

Source PubMed

Download CSV of topics

Grants14

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U01 HL105198NHLBI NIH HHSUnited StatesU01HL105198PubMed and NIHNIH RePORTER
R24 GM061374NIGMS NIH HHSUnited StatesR24GM061374PubMed and NIHNIH RePORTER
U01 GM074492NIGMS NIH HHSUnited StatesU01GM074492PubMed and NIHNIH RePORTER
U19 HL065962NHLBI NIH HHSUnited StatesU01HL065962PubMed and NIHNIH RePORTER
KL2 TR000069NCATS NIH HHSUnited StatesKL2TR000069PubMed and NIHNIH RePORTER
U01HL105198NHLBI NIH HHSUnited StatesU01HL105198PubMed and NIHNIH RePORTER
U01 HL065962NHLBI NIH HHSUnited StatesU01HL065962PubMed and NIHNIH RePORTER
U01GM92666NIGMS NIH HHSUnited StatesU01GM092666PubMed and NIHNIH RePORTER
KL2TR000069NCATS NIH HHSUnited StatesKL2TR000069PubMed and NIHNIH RePORTER
U01 GM092666NIGMS NIH HHSUnited StatesU01GM092666PubMed and NIHNIH RePORTER
U19HL065962-10NHLBI NIH HHSUnited StatesU19HL065962PubMed and NIHNIH RePORTER
U01GM074492NIGMS NIH HHSUnited StatesU01GM074492PubMed and NIHNIH RePORTER
U01HL65962NHLBI NIH HHSUnited StatesU01HL065962PubMed and NIHNIH RePORTER
R24GM61374NIGMS NIH HHSUnited StatesR24GM061374PubMed and NIHNIH RePORTER

Download CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT05091879Preemptive Pharmacogenomics Testing Among Geriatric PatientsBackgroundClinicalTrials.gov
NCT05763862Genotype Guided Antiplatelet Therapy In Ischemic StrokeBackgroundClinicalTrials.gov

Download CSV of trials

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120062936Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study.Thromb Haemost2010https://conductscience.org/library/papers/20062936PubMed
222809746
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol2012https://conductscience.org/library/papers/22809746PubMed
319106083Genetic determinants of response to clopidogrel and cardiovascular events.N Engl J Med2009https://conductscience.org/library/papers/19106083PubMed
419717846Ticagrelor versus clopidogrel in patients with acute coronary syndromes.N Engl J Med2009https://conductscience.org/library/papers/19717846PubMed
516772608Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects.Blood2006https://conductscience.org/library/papers/16772608PubMed
619108880Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study.Lancet2009https://conductscience.org/library/papers/19108880PubMed
722513313Clopidogrel: a case for indication-specific pharmacogenetics.Clin Pharmacol Ther2012https://conductscience.org/library/papers/22513313PubMed
822028352Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis.JAMA2011https://conductscience.org/library/papers/22028352PubMed
920801498Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial.Lancet2010https://conductscience.org/library/papers/20801498PubMed
1021270786CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.Clin Pharmacol Ther2011https://conductscience.org/library/papers/21270786PubMed
1123809542The CYP2C19*17 variant is not independently associated with clopidogrel response.J Thromb Haemost2013https://conductscience.org/library/papers/23809542PubMed
1221716271Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.Clin Pharmacol Ther2011https://conductscience.org/library/papers/21716271PubMed
1319706858Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.JAMA2009https://conductscience.org/library/papers/19706858PubMed
1419487603Can we override clopidogrel resistance?Circulation2009https://conductscience.org/library/papers/19487603PubMed
1522027650PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19.Pharmacogenet Genomics2012https://conductscience.org/library/papers/22027650PubMed
1620083681Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.Circulation2010https://conductscience.org/library/papers/20083681PubMed
1719496924The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome.J Thromb Haemost2009https://conductscience.org/library/papers/19496924PubMed
1818055486
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease.
Eur Heart J2008https://conductscience.org/library/papers/18055486PubMed
1919268736Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis.Am J Cardiol2009https://conductscience.org/library/papers/19268736PubMed
2019106084Cytochrome p-450 polymorphisms and response to clopidogrel.N Engl J Med2009https://conductscience.org/library/papers/19106084PubMed

See all 40 referencesDownload CSV of references

Cited by434

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 722 citations.

PMIDTitleJournalYearIn PapersSource
42865374A prospective study evaluating clopidogrel resistance among patients with ischemic cerebrovascular events across different ethnic groups in Israel.Front Stroke2026https://conductscience.org/library/papers/42865374PubMed
42799099Implementation of preemptive pharmacogenetic testing: progress, puzzles and priorities from an implementation science perspective.Front Pharmacol2026https://conductscience.org/library/papers/42799099PubMed
42703526Association Between CYP450 Polymorphisms and Treatment Outcomes of Escitalopram and Venlafaxine in Patients with Post Stroke Depression.Neuropsychiatr Dis Treat2026https://conductscience.org/library/papers/42703526PubMed
42677320Repositioning candidate gene approaches in the post-GWAS era: a clinical perspective from psychiatric pharmacogenetics.Front Genet2026https://conductscience.org/library/papers/42677320PubMed
42583968Effectiveness of pharmacogenomics-guided dosing in improving treatment outcomes.Indian J Pharmacol2026https://conductscience.org/library/papers/42583968PubMed
42534206Long-Term Antithrombotic Therapy After Percutaneous Coronary Intervention: Secondary Prevention Beyond One Year.Rev Cardiovasc Med2026https://conductscience.org/library/papers/42534206PubMed
42195352The Role of Next-Generation Sequencing in Cardiovascular Disease: A New Era of Precision Cardiology.Life (Basel)2026https://conductscience.org/library/papers/42195352PubMed
42188087Is Aspirin Still Indispensable After PCI-Rethinking Dual Antiplatelet Therapy in Contemporary Practice.J Cardiovasc Dev Dis2026https://conductscience.org/library/papers/42188087PubMed
42115787Limited Visibility and Perception of the Clinical Relevance of Clopidogrel Pharmacogenetics in Cardiology Literature.Clin Transl Sci2026https://conductscience.org/library/papers/42115787PubMed
42051361Exploring Influencing Factors Including CYP2C19 Genotypes, and Developing a Machine Learning-Based Predictive Model for Clopidogrel Resistance in Chinese Patients with Ischemic Stroke.Int J Gen Med2026https://conductscience.org/library/papers/42051361PubMed
42042550The Environmental and Global Impact of Pharmacogenomics: Advancing Green Pharmacy Toward Sustainable and Inclusive Precision Medicine.J Pers Med2026https://conductscience.org/library/papers/42042550PubMed
41893359Pharmacometabolomics Detects Unreported Clopidogrel Metabolites in the Urine of Kidney and Liver Transplant Recipients.Metabolites2026https://conductscience.org/library/papers/41893359PubMed
41847134Prevalence of actionable pharmacogenomic variants in Brazilian patients with cancer.Front Pharmacol2026https://conductscience.org/library/papers/41847134PubMed
41760043Antiplatelet dilemma: Clopidogrel or aspirin for long-term cardiovascular protection after dual antiplatelet therapy following PCI.Medicine (Baltimore)2026https://conductscience.org/library/papers/41760043PubMed
41749019CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026.Cardiovasc Interv Ther2026https://conductscience.org/library/papers/41749019PubMed
41728397Clinical Pharmacogenomic Variants Among the Saudi Population and Their Impact on Drug Response: A Review of Saudi-Based Evidence.Cureus2026https://conductscience.org/library/papers/41728397PubMed
41652975Importance of genetic ancestry in pharmacogenomics for precision medicine.Pharmacogenomics2025https://conductscience.org/library/papers/41652975PubMed
41617356Efficacy and safety of off-label low-dose compared with standard-dose antiplatelet agents in patients with coronary heart disease: a meta-analysis.Open Heart2026https://conductscience.org/library/papers/41617356PubMed
41471361Association Between CYP2C9 and CYP2C19 Genetic Polymorphisms and Antiseizure Medication-Induced Adverse Reactions Among Peruvian Patients with Epilepsy.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41471361PubMed
41338248CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).Br J Clin Pharmacol2026https://conductscience.org/library/papers/41338248PubMed

See all 434 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CYP2C191557PubTator's text mininghttps://conductscience.org/library/genes/1557

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23698643

GET https://conductscience.org/api/papers/v1/23698643/references?page=2